figshare
Browse
Marsh_Pers-StratMedNov2014.pptx (3.05 MB)

Personalized Medicine - Opportunities for Chemistry

Download (0 kB)
Version 2 2014-12-01, 14:09
Version 1 2014-12-01, 14:00
presentation
posted on 2014-12-01, 14:00 authored by Andrew MarshAndrew Marsh, Paul C Taylor, Katherine Casey-Green, John Watkins, Donald RJ Singer

Talk delivered at Warwick Biomedical Engineering Seminar series 27 November 2014.  Develops a theme emerging from a review in 2010:

J Watkins, A Marsh, P C Taylor, D R J Singer
Therapeutic Delivery, 2010, 1, 651-665

 

"Continued adherence to a single-drug single-target paradigm will limit the ability of chemists to contribute to advances in personalized medicine, whether they be in discovery or delivery"

 

History

Usage metrics

    Categories

    Keywords

    polypharmacologytyrosine kinase activityTyrosine KinasecancerKinase inhibitorsstatinstransportersorganic anion transportersABC transporterscell biologymedicinebiomedicinepharmacologyCardiovascular pharmacologypharmacology/personalized medicinePersonalized medicinemedicinal chemistrydrug discoveryopen drug discovery teamsBioinformaticsScience PolicyPathologyCheminformaticsDiseasesMolecular BiologyMedicineBiochemistryCancerBiophysicsHealth CareOrganic ChemistryPharmacologyCardiologyComputational BiologyCell BiologyGeneticsBiomarkers

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC